Medicamen Organics Limited Reports Robust Growth in FY25: Revenue Up 51%, PAT Doubles in H2
Medicamen Organics Limited has announced impressive financial results for FY25, showcasing strong performance across key metrics. The company reported a 51% year-on-year surge in revenue
